Search by Drug Name or NDC

    NDC 00713-0805-99 TAZAROTENE 0.5 mg/g Details

    TAZAROTENE 0.5 mg/g

    TAZAROTENE is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is TAZAROTENE.

    Product Information

    NDC 00713-0805
    Product ID 0713-0805_0b4ad65c-1d55-3e68-e063-6294a90a8e54
    Associated GPIs
    GCN Sequence Number 031600
    GCN Sequence Number Description tazarotene GEL (GRAM) 0.05 % TOPICAL
    HIC3 L5F
    HIC3 Description ANTIPSORIATICS AGENTS
    GCN 29221
    HICL Sequence Number 013315
    HICL Sequence Number Description TAZAROTENE
    Brand/Generic Generic
    Proprietary Name TAZAROTENE
    Proprietary Name Suffix n/a
    Non-Proprietary Name tazarotene
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form GEL
    Route TOPICAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/g
    Substance Name TAZAROTENE
    Labeler Name Cosette Pharmaceuticals, Inc.
    Pharmaceutical Class Retinoid [EPC], Retinoids [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA215433
    Listing Certified Through 2024-12-31

    Package

    NDC 00713-0805-99 (00713080599)

    NDC Package Code 0713-0805-99
    Billing NDC 00713080599
    Package 1 TUBE in 1 CARTON (0713-0805-99) / 100 g in 1 TUBE
    Marketing Start Date 2022-09-14
    NDC Exclude Flag N
    Pricing Information N/A